Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage
Authors:
- 21 February 2015
- journal article
- clinical trial
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 157 (5) , 763-767
Abstract
The aim of this study was to evaluate serum nimodipine concentrations in patients with aneurysmal subarachnoid hemorrhage (SAH) after parenteral therapy and a following course of enteral administration. SAH patients were treated with intravenous nimodipine (2 mg/h) during the 1st week after hemorrhage, and on day 8, we switched over to enteral administration (60 mg/4 h), either orally or by gavage. Serum nimodipine concentrations were measured on days 3, 5, 8, 9 and 12. Area under the curve (AUC) was calculated during parenteral and enteral therapy. The data of 15 patients were analyzed retrospectively. In this study, 157 blood samples were obtained. In seven samples, during the administration by gavage to two patients with high-grade SAH, the serum nimodipine concentrations were negligible. The AUC values during parenteral administration (median 149.3 ng-h/ml) were significantly higher than during oral administration on days 9 (median 92.1 ng-h/ml) and 12 (median 44.1 ng-h/ml) in seven patients (p = 0.030 and p = 0.016, respectively). The AUC values during parenteral administration were significantly higher than during administration by gavage on day 9 in eight patients (median 87.9 and 34 ng-h/ml, respectively, p = 0.001). The AUC values during enteral administration were higher in patients who received nimodine orally than in those who received it by gavage (median 52.3 and 23.1 ng-h/ml, respectively, p = 0.006). Enteral administration of nimodipine showed lower bioavailability during the 2nd week after SAH compared to parenteral application during the 1st week. Negligible serum concentrations were even expected when nimodipine was given by gavage in patients with high-grade SAH, thus suggesting that parenteral administration may be the better route in these patients.Keywords
This publication has 16 references indexed in Scilit:
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2012
- Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administrationJournal of Neurosurgery, 2009
- Calcium antagonists for aneurysmal subarachnoid haemorrhageCochrane Database of Systematic Reviews, 2007
- The impact of admission diagnosis on gastric emptying in critically ill patientsCritical Care, 2007
- Pharmacokinetic Changes in Critical IllnessCritical Care Clinics, 2006
- QTc dispersion as a marker for medical complications after severe subarachnoid haemorrhageEuropean Journal of Anaesthesiology, 2003
- Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management?Intensive Care Medicine, 2002
- NimodipineDrugs & Aging, 1995
- Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.BMJ, 1989
- Surgical Risk as Related to Time of Intervention in the Repair of Intracranial AneurysmsJournal of Neurosurgery, 1968